Abstract:Background/aims: Inflammatory bowel disease (IBD) is a common disease associated with disorders of the innate and adaptive immune response.Sulforaphane (SFN), a phytochemical in broccoli sprouts, is well known to have anti-inflammatory, antitumor and antioxidative properties.regulates activation of the innate immune system.We aimed to determine Sulforaphane alleviates dextran sodium sulfate (DSS)-induced inflammation through miR-155a in macrophages, and evaluated the miR-155 related mechanisms of Sulforaphane effects on inflammation and polarization in macrophage.Experimental approach: C57BL/6 mice received DSS (2%) in drinking water with 30 mg/kg intraperitoneal (i.p.) injection either 0.9% normal saline (NS) as control or SFN for 7 days.RAW264.7 cells were stimulated by lipopolysaccharide (LPS) and/or 20uM SFN for different hours to detect mRNA and protein levels.Results: We observed that SFN improved survival rate, reduced serum levels of pro-inflammatory cytokines IL-1β, IL-6, IL-18 and lowered histopathology scores after DSS-induced colitis.SFN affected the polarization status of intestinal macrophages evidenced by the increase of M2 marker Arg-1 and CD206 expression and the decrease of M1 marker iNOS and CD86 expression along with an increased Th2 cytokine IL-10 and decreased Th1 cytokine TNF-α in colon tissues and macrophages.Simultaneously, the inflammasome reduction of NLRP3 accompanied with increased polarization of phenotype resembling M2 macrophages.SFN markedly downregulated miR-155a in mouse colon and macrophages.As a target of miR-155, Quaking (QKI) is an inflammation-suppressor gene encoding a conserved RNA-binding protein.SFN reversed LPS-induced downregulation of QkI and QKI-dependent activated aryl hydrocarbon receptor (Ahr) expression both in mRNA and protein level.Introduction miR-155 expression in macrophages is induced by NF-kB and regulated by STATs.To identified how SFN regulates miR-155 in macrophages, We also analyzed NF-kB and STATs.SFN treatment inhibited phosphorylation of NF-κB p65 and STAT3 signal transducer, but enhanced STAT1 phosphorylation in LPS-induced macrophages.For further investigation, although Ahr was mediated by miR-155, Ahr responsed to negative feedback in NF-κB via form a complex with Stat1 and NF-κB p50 in LPS-induced macrophages after SFN stimulate.Ahr inhibited the NF-κB transcriptional activity and prolonged STAT1 activation.Conclusions: Our findings suggest that SFN protects DSS-induced colitis by switches macrophages polarization states in inflammation and defectives NLRP3 inflammasome activation.MiR-155 is a key regulator of Inhibiting proinflammatory for SFN treatment in macrophages.Ahr as a target of miR-155/QKI pathway also control S-491 AGA Abstracts and regulate Stat1/NF-κB/Ahr complex.Therefore, SFN might be a potential therapeutic agent for the treatment of IBD.

Lack of bone marrow stromal cell antigen-1 (BST-1)/CD157 ameliorated colitis induced by dextran sodium sulfate (DSS)

Amelioration of Dextran Sulfate Sodium-Induced Experimental Ulcer Colitis in Mice by Bacillus licheniformis

Isosteviol Attenuates DSS-induced Colitis by Maintaining Intestinal Barrier Function Through PDK1/AKT/NF-κB Signaling Pathway

P101 Isosteviol Attenuates Dextran Sulfate Sodium-Induced Colitis by Maintaining the Intestinal Barrier Through PDK1/AKT/NF-κB Signaling

The effect of oral tolerance on the roles of small intestinal intraepithelial lymphocytes in murine colitis induced by dextran sodium sulfate

Alleviation Effects of Bifidobacterium animalis subsp. lactis XLTG11 on Dextran Sulfate Sodium-Induced Colitis in Mice

The Role of CD19+CD5+CD1dhi B Cells in Dextran Sulfact Sodium (dss)induced Inflammatory Bowel Disease C57BL/6 Mouse Model

Protective Effect of Saccharomyces Boulardii on Intestinal Mucosal Barrier of Dextran Sodium Sulfate-Induced Colitis in Mice

The role of CD19+ CD5+ CD1dhi B cells in dextran sulfact sodium (DSS)

Heat-Killed Bifidobacterium bifidum B1628 May Alleviate Dextran Sulfate Sodium-Induced Colitis in Mice, and the Anti-Inflammatory Effect Is Associated with Gut Microbiota Modulation

Btbd8 deficiency reduces susceptibility to colitis by enhancing intestinal barrier function and suppressing inflammation

Protein Tyrosine Phosphatase 1B Deficiency Ameliorates Murine Experimental Colitis Via the Expansion of Myeloid-Derived Suppressor Cells.

Resistant Maltodextrin Alleviates Dextran Sulfate Sodium-Induced Intestinal Inflammatory Injury by Increasing Butyric Acid to Inhibit Proinflammatory Cytokine Levels

<i>Saccharomyces boulardii</i> alleviates DSS-induced intestinal barrier dysfunction and inflammation in humanized mice

Bacteroides dorei BDX-01 alleviates DSS-induced experimental colitis in mice by regulating intestinal bile salt hydrolase activity and the FXR-NLRP3 signaling pathway

MD-1 Deficiency Attenuates Dextran Sodium Sulfate (Dss)-Induced Colitis Through Modulating the Function of Colonic Lamina Propria Dendritic Cells

Anti-inflammatory Effect of Bifidobacterium Animalis Subsp. Lactis A6 on DSS-induced Colitis in Mice.

Su1038 – Nod1 Deficient Gastric Stem Cells Fail to Differentiate to Parietal Cells and Cause Gastric Mucosal Atrophy

The Role of Th17/Treg Balance and Th22 Cell in the Pathogenesis of DSS-induced Colitis in Mice

Galactooligosaccharides Protects Against DSS-induced Murine Colitis Through Regulating Intestinal Flora and Inhibiting NF-κB Pathway.

Pretreatment with Bifidobacterium longum BAA2573 ameliorates dextran sulfate sodium (DSS)-induced colitis by modulating gut microbiota